Small cell lung cancer: Time to revisit DNA-damaging chemotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27384345.
- Also identified by DOI 10.1126/scitranslmed.aaf6282 and PMC identifier 7821960.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rational use of DNA-damaging chemotherapy, with new combinations to heighten DNA replication stress, could improve outcomes in small cell lung cancer.
Medical subject headings
- DNA Damage
- Drug Therapy
- Lung Neoplasms
- Small Cell Lung Carcinoma